Why is there no treatment for osteoarthritis – Opportunity for AI based big data analytics to advance the field
Osteoarthritis and Cartilage · 2025
DOI: 10.1016/j.joca.2025.12.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Osteoarthritis and Cartilage, 2025. Verfasst von F Saxer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Biomedical Research, Novartis Campus, Basel 4002, Switzerland; Medical Faculty, University of Basel, Basel 4002, Switzerland. Electronic add…. Hauptthemen laut MEDLINE: Osteoarthritis, Big Data, Machine Learning. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) has long been researched but insights have not translated into novel treatments for OA. One reason may be the heterogeneity of patients suffering from OA. Developments in machine-learning (ML) especially privacy-preserving, federated approaches could help to detect patterns of patient characteristics that allow better segmentation of patient populations, generate prognostic insights on disease progression, and define regulatory acceptable pathways towards patient-relevant surrogate endpoints. OPPORTUNITY: The article describes the vision of a collaborative inter-professional, inter-institutional and public-private activity leveraging the wealth of rich yet fragmented datasets to achieve this goal. We summarize the underlying assumptions, challenges and potential applications of such an ML-based approach. USE CASES: Employing federated training algorithms locally has the advantage of preserving privacy. The application of novel ML techniques to divers sets of multidimensional health care data such as registries, real-world evidence, trial data etc. allows not only prognostic and predictive inferences but can also overcome issues with incompleteness of variables, heterogeneity in database structures and multidimensionality of variables. This exploration of data can form the foundation for the development of covariates, digital twins, synthetic control groups and form a potential basis for trial emulation. In addition, the approach will enable the development of novel (surrogate) endpoints and inform enrichment strategies. CONCLUSION: Leveraging ML in a federated framework, the richness of data on OA and the expertise from various areas including patients, providers, ethicists and regulators has the potential to revolutionize trial designs in OA and finally meet the needs of patients suffering from OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Novartis Biomedical Research, Novartis Campus, Basel 4002, Switzerland; Medical Faculty, University of Basel, Basel 4002, Switzerland. Electronic address: franziska.saxer@novartis.com.
- Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: gunther.jansen@novartis.com.
- Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of General Practice, Erasmus MC University Medical Center Rotterdam, Rotterdam, the N…
- Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: bjoern.holzhauer@novartis.com.
- Novartis Pharma AG, Basel 4002, Switzerland. Electronic address: david.demanse@novartis.com.
- Capgemini, UK. Electronic address: justin.melnick@capgemini.com.
Zitieren
APA
Saxer, F., Jansen, G., Bierma-Zeinstra, S. M. A., Holzhauer, B., Demanse, D., Melnick, J., Vukadinovic Greetham, D., Rall, T., Mesenbrink, P., & Schieker, M. (2025). Why is there no treatment for osteoarthritis – Opportunity for AI based big data analytics to advance the field. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.12.021
Vancouver
Saxer F, Jansen G, Bierma-Zeinstra SMA, Holzhauer B, Demanse D, Melnick J, et al. Why is there no treatment for osteoarthritis – Opportunity for AI based big data analytics to advance the field. Osteoarthritis and Cartilage. 2025. doi:10.1016/j.joca.2025.12.021
BibTeX
@article{Saxer2025,
author = {Saxer, F and Jansen, G and Bierma-Zeinstra, S M A and Holzhauer, B and Demanse, D and Melnick, J and Vukadinovic Greetham, D and Rall, T and Mesenbrink, P and Schieker, M},
title = {Why is there no treatment for osteoarthritis – Opportunity for AI based big data analytics to advance the field},
journal = {Osteoarthritis and Cartilage},
year = {2025},
doi = {10.1016/j.joca.2025.12.021}
}
EUVIMED